Q: Ben, you're the EIPM's Director of Ex Vivo Models. Can you explain what you do?
A: Sure. The EIPM Ex Vivo Models Group receives tissues from patients with cancer, usually advanced cases. Our team builds organoid models of these tumors to test different therapeutics, aiming to find new treatments and improve patient care. The overarching goal is to translate research findings into the clinic to benefit patients.
Dear Friends & Members of the Englander Institute,
We are looking for EIPM Journal Club speakers for in-person meetings (in either Belfer 1401 or Greenberg Y1301). Journal Club topics can vary, including but not limited to: precision medicine, genetics, and artificial intelligence in medicine, among other...
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells. The technology,...
We are looking for EIPM Journal Club speakers for in-person meetings (in either Belfer 1401 or Greenberg Y1301). Journal Club topics can vary, including but not limited to: precision medicine, genetics, and artificial intelligence in medicine, among other...